Physician profile
Aaron P Danison
NPI 1750608527
$3,054.84
in general payments reported to CMS, 2019-2025
16 companies · $63.32 in 2025
The $63.32 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,734 · 2020: $254 · 2021: $239 · 2022: $545 · 2023: $163 · 2024: $56.23 · 2025: $63.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,098.13 | 2019 | |
| Medtronic, INC. | $763.96 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Mazor X System |
| Depuy Synthes Sales INC. | $408.18 | 2019-2023 | Vivigen Mis Delivery System |
| Medtronic USA, INC. | $400.53 | 2019-2020 | |
| Si-Bone, INC. | $75.41 | 2019-2022 | |
| Stryker Corporation | $53.50 | 2020 | |
| Boston Scientific Corporation | $50.13 | 2019-2022 | |
| Irras USA, INC. | $42.07 | 2020-2021 | |
| Orthofix Medical, INC. | $32.73 | 2019 | |
| Nevro Corp. | $28.04 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.88 | 2024 | Andexxa |
| Baxter Healthcare | $22.00 | 2025 | Floseal |
| Kerecis Limited | $17.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $14.12 | 2019 | |
| Abbott Laboratories | $13.36 | 2023 | Infinity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Danison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.